May 28, 2026 · Form 4 insider transaction
Carver Kyle bought 15,000 shares of Evommune, Inc. at $2.99 per share, a transaction worth $44.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 26, 2026.